187 related articles for article (PubMed ID: 28491038)
1. Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.
Tabuchi M; Mizuno K; Mizoguchi K; Hattori T; Kase Y
Front Pharmacol; 2017; 8():235. PubMed ID: 28491038
[TBL] [Abstract][Full Text] [Related]
2. Effect of Yokukansan and Yokukansankachimpihange on Aggressive Behavior, 5-HT Receptors and Arginine Vasopressin Expression in Social Isolation-Reared Mice.
Iba H; Watanabe T; Matsuzawa K; Saimiya M; Tanaka M; Nagao M; Moriyama H; Kubota K; Katsurabayashi S; Iwasaki K
Biol Pharm Bull; 2019; 42(12):2009-2015. PubMed ID: 31787717
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Effects of Yokukansan and Yokukansankachimpihange on Glutamate Uptake by Cultured Astrocytes and Glutamate-Induced Excitotoxicity in Cultured PC12 Cells.
Kawakami Z; Omiya Y; Mizoguchi K
Evid Based Complement Alternat Med; 2019; 2019():9139536. PubMed ID: 31263507
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS detection of citrus unshiu peel-derived flavonoids in the plasma and brain after oral administration of yokukansankachimpihange in rats.
Takiyama M; Matsumoto T; Watanabe J
Xenobiotica; 2019 Dec; 49(12):1494-1503. PubMed ID: 30741064
[TBL] [Abstract][Full Text] [Related]
5. Yokukansankachimpihange, a traditional Japanese (Kampo) medicine, enhances the adaptation to circadian rhythm disruption by increasing endogenous melatonin levels.
Imamura S; Tabuchi M; Oizumi H; Ueki T; Omiya Y; Ikarashi Y; Mizoguchi K
J Pharmacol Sci; 2020 Nov; 144(3):129-138. PubMed ID: 32921394
[TBL] [Abstract][Full Text] [Related]
6. Influences of yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats.
Tamano H; Yusuke E; Ide K; Takeda A
Exp Anim; 2016 Nov; 65(4):353-361. PubMed ID: 27245118
[TBL] [Abstract][Full Text] [Related]
7. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.
Kanno H; Sekiguchi K; Yamaguchi T; Terawaki K; Yuzurihara M; Kase Y; Ikarashi Y
J Pharm Pharmacol; 2009 Sep; 61(9):1249-56. PubMed ID: 19703376
[TBL] [Abstract][Full Text] [Related]
8. Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.
Mizoguchi K; Ikarashi Y
Front Pharmacol; 2017; 8():149. PubMed ID: 28377723
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease: A study protocol of a randomized, double blind, placebo-controlled pilot trial.
Jang JH; Lee J; Jung I; Yoo H
Medicine (Baltimore); 2018 Jun; 97(26):e11298. PubMed ID: 29953013
[TBL] [Abstract][Full Text] [Related]
10. Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice.
Fujiwara H; Han Y; Ebihara K; Awale S; Araki R; Yabe T; Matsumoto K
BMC Complement Altern Med; 2017 Apr; 17(1):195. PubMed ID: 28376888
[TBL] [Abstract][Full Text] [Related]
11. Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.
Katahira H; Sunagawa M; Watanabe D; Kanada Y; Katayama A; Yamauchi R; Takashima M; Ishikawa S; Hisamitsu T
Neuropsychiatr Dis Treat; 2017; 13():863-872. PubMed ID: 28360524
[TBL] [Abstract][Full Text] [Related]
12. Yokukansankachimpihange Improves the Social Isolation-Induced Sleep Disruption and Allopregnanolone Reduction in Mice.
Murata K; Li F; Shinguchi K; Ogata M; Fujita N; Takahashi R
Front Nutr; 2020; 7():8. PubMed ID: 32118027
[TBL] [Abstract][Full Text] [Related]
13. Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients.
Ikarashi Y; Mizoguchi K
Pharmacol Ther; 2016 Oct; 166():84-95. PubMed ID: 27373856
[TBL] [Abstract][Full Text] [Related]
14. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin ₁A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan.
Nishi A; Yamaguchi T; Sekiguchi K; Imamura S; Tabuchi M; Kanno H; Nakai Y; Hashimoto K; Ikarashi Y; Kase Y
Neuroscience; 2012 Apr; 207():124-36. PubMed ID: 22314317
[TBL] [Abstract][Full Text] [Related]
15. Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635.
Balducci C; Nurra M; Pietropoli A; Samanin R; Carli M
Psychopharmacology (Berl); 2003 Apr; 167(1):28-36. PubMed ID: 12618916
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K
J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784
[TBL] [Abstract][Full Text] [Related]
17. Ameliorative effect of traditional Japanese medicine yokukansan on age-related impairments of working memory and reversal learning in rats.
Mizoguchi K; Shoji H; Tanaka Y; Tabira T
Neuroscience; 2011 Mar; 177():127-37. PubMed ID: 21195139
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
[TBL] [Abstract][Full Text] [Related]
19. Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells.
Terawaki K; Ikarashi Y; Sekiguchi K; Nakai Y; Kase Y
J Ethnopharmacol; 2010 Feb; 127(2):306-12. PubMed ID: 19913081
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats.
Kanada Y; Katayama A; Ikemoto H; Takahashi K; Tsukada M; Nakamura A; Ishino S; Hisamitsu T; Sunagawa M
Neuropsychiatr Dis Treat; 2018; 14():937-944. PubMed ID: 29670354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
